The continuous, real-time measurement of specific molecules in situ in the body would
greatly improve our ability to understand, diagnose, and treat disease. The vast majority of …

The ultimate goal of implantable bioanalytical sensors is to enable the continuous and
precise monitoring of clinically and physiologically important targets in the body for …

The ability to monitor drugs, metabolites, hormones, and other biomarkers in situ in the body
would greatly advance both clinical practice and biomedical research. To this end, we are …

The need to calibrate to correct for sensor-to-sensor fabrication variation and sensor drift has
proven a significant hurdle in the widespread use of biosensors. To maintain clinically …

The development of a technology capable of tracking the levels of drugs, metabolites, and
biomarkers in the body continuously and in real time would advance our understanding of …

Electrochemical aptamer-based (EAB) sensors are capable of measuring the concentrations
of specific molecules in vivo, in real time, and with a few-second time resolution. For their …

The continuous, real-time monitoring of specific molecular targets in unprocessed clinical
samples would enable many transformative medical applications. Electrochemical aptamer …

Electrochemical aptamer-based (E-AB) biosensors afford real-time measurements of the
concentrations of molecules directly in complex matrices and in the body, offering alternative …

Electrochemical aptasensors, which are based on the specificity of aptamer-target
recognition, with electrochemical transduction for analytical purposes have received …

Electrochemical, aptamer-based (E-AB) sensors support the continuous, real-time
measurement of specific small molecules directly in situ in the living body over the course of …